Diabetes Care Devices - Morocco | Statista Market Forecast

In Morocco, revenue in the Diabetes Care Devices market market is anticipated to reach US$30.44m in 2024.
The revenue is forecasted to exhibit an annual growth rate (CAGR 2024-2029) of 12.98%, culminating in a market volume of US$56.04m by 2029.
In comparison on a global scale, the majority of revenue will be produced the United States, which is projected to generate US$11.71bn in 2024.
The Diabetes Care Devices market in Morocco is experiencing a surge in demand due to increasing awareness and rising prevalence of diabetes among the population.

Definition:
The Diabetes Care Devices market, a medical technology market, includes medical devices used in the management and treatment of diabetes. These devices range from blood glucose meters and continuous glucose monitoring systems to insulin pumps, insulin pens, and other related accessories. It is important to note that the market does not include pharmaceutical products used in the treatment of diabetes, such as insulin and oral hypoglycemic agents.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.

Key players in the market include Medtronic, Abbott Laboratories, and Roche Diagnostics. Further information on the key players can be found in the Market Shares boxes.

Blood glucose monitoring devices
Insulin delivery devices

Diabetes drugs
Diabetes supplements

The Diabetes Care Devices Market in Morocco is witnessing considerable growth, fueled by factors such as increasing prevalence of diabetes, heightened awareness of health management, and advancements in technology that enhance patient convenience and monitoring efficiency.

Customer preferences: Consumers in Morocco are increasingly prioritizing personalized diabetes care solutions that cater to their unique cultural and lifestyle needs. There is a growing demand for user-friendly glucose monitoring devices that integrate with mobile apps, enabling real-time tracking and tailored health insights. Additionally, as more young people adopt healthier lifestyles, there is a shift towards preventive care, with an emphasis on education and community support programs. This trend is further bolstered by rising internet penetration, facilitating access to digital health resources and telemedicine services.

Trends in the market: In Morocco, the Diabetes Care Devices Market is experiencing a notable shift towards personalized glucose monitoring solutions that reflect local cultural and lifestyle factors. The demand for user-friendly, app-integrated devices is growing, enabling real-time health tracking and individualized insights. Concurrently, there is an increasing focus on preventive care among the youth, supported by educational initiatives and community health programs. This trend, fueled by rising internet access, is paving the way for enhanced digital health resources and telemedicine, presenting significant opportunities for industry stakeholders to innovate and expand their offerings in this evolving landscape.

Local special circumstances: In Morocco, the Diabetes Care Devices Market is shaped by the country's diverse geography and cultural attitudes toward health. The predominance of urban areas fosters a demand for connected health technologies, while rural regions face challenges in access to care, influencing device design and distribution strategies. Additionally, cultural factors emphasize community and family involvement in health management, driving interest in user-friendly, shared monitoring solutions. Regulatory frameworks are evolving, encouraging innovation and local partnerships, which enhances market dynamics and promotes tailored diabetes care solutions.

Underlying macroeconomic factors: The Diabetes Care Devices Market in Morocco is significantly influenced by macroeconomic factors such as national economic health, investment in healthcare infrastructure, and global economic trends. The rising prevalence of diabetes, coupled with a growing awareness of chronic disease management, propels demand for innovative devices. Fiscal policies promoting public health initiatives and subsidies for medical technologies enhance accessibility, particularly in urban areas. Conversely, economic disparities in rural regions challenge consistent market growth. Additionally, global trends toward telemedicine and remote patient monitoring are shaping local device innovations, reinforcing the need for adaptable and cost-effective diabetes care solutions tailored to diverse populations.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.